Acute myeloid leukemia and NK cells: two warriors confront each other

被引：34

作者：

Baragano Raneros, Aroa ^{[1
]}

Lopez-Larrea, Carlos ^{[1
,2
]}

Suarez-Alvarez, Beatriz ^{[1
]}

机构：

[1] Hosp Univ Cent Asturias, Inst Invest Sanitaria Principado Asturias ISPA, Translat Immunol Lab, Av Roma S-N, Oviedo 33011, Spain

[2] Hosp Univ Cent Asturias, Immunol Dept, Oviedo, Spain

来源：

ONCOIMMUNOLOGY | 2019年 / 8卷 / 02期

关键词：

Acute myeloid leukemia; natural killer cells; NKG2D; CAR-T; immunotherapy; immune checkpoints; NATURAL-KILLER-CELL; CHIMERIC ANTIGEN RECEPTORS; NKG2D LIGAND EXPRESSION; T-CELLS; ACTIVATING RECEPTORS; EFFECTOR FUNCTIONS; VALPROIC ACID; STEM-CELLS; ANTITUMOR; CANCER;

D O I：

10.1080/2162402X.2018.1539617

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Acute myeloid leukemia (AML) is a heterogeneous disease whose therapies currently show elevated toxicity and a high rate of relapse. Recently, the burgeoning of new anti-tumor therapeutic strategies aimed at enhancing the immune response has pushed natural killer cells (NKs) into the spotlight. These cells are powerful warriors that can bring about the lysis of tumor cells through their cytotoxic ability. However, tumor cells have developed strategies to evade recognition mediated by NKs. Here, we review the mechanisms triggered by AML cells and discuss the emerging immunotherapeutic strategies that potentiate the anti-tumor functions of NKs.

引用

页数：11

共 75 条

[31] CD33-specific chimeric antigen receptor T cells exhibit potent preclinical activity against human acute myeloid leukemia [J].

Kenderian, S. S. ;

Ruella, M. ;

Shestova, O. ;

Klichinsky, M. ;

Aikawa, V. ;

Morrissette, J. J. D. ;

Scholler, J. ;

Song, D. ;

Porter, D. L. ;

Carroll, M. ;

June, C. H. ;

Gill, S. .

LEUKEMIA, 2015, 29 (08) :1637-1647

[32] A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression [J].

Kikushige, Yoshikane ;

Miyamoto, Toshihiro ;

Yuda, Junichiro ;

Jabbarzadeh-Tabrizi, Siamak ;

Shima, Takahiro ;

Takayanagi, Shin-ichiro ;

Niiro, Hiroaki ;

Yurino, Ayano ;

Miyawaki, Kohta ;

Takenaka, Katsuto ;

Iwasaki, Hiromi ;

Akashi, Koichi .

CELL STEM CELL, 2015, 17 (03) :341-352

[33] Licensing of natural killer cells by host major histocompatibility complex class I molecules [J].

Kim, S ;

Poursine-Laurent, J ;

Truscott, SM ;

Lybarger, L ;

Song, YJ ;

Yang, LP ;

French, AR ;

Sunwoo, JB ;

Lemieux, S ;

Hansen, TH ;

Yokoyama, WM .

NATURE, 2005, 436 (7051) :709-713

[34] Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia [J].

Klco, Jeffery M. ;

Spencer, David H. ;

Miller, Christopher A. ;

Griffith, Malachi ;

Lamprecht, Tamara L. ;

O'Laughlin, Michelle ;

Fronick, Catrina ;

Magrini, Vincent ;

Demeter, Ryan T. ;

Fulton, Robert S. ;

Eades, William C. ;

Link, Daniel C. ;

Graubert, Timothy A. ;

Walter, Matthew J. ;

Mardis, Elaine R. ;

Dipersio, John F. ;

Wilson, Richard K. ;

Ley, Timothy J. .

CANCER CELL, 2014, 25 (03) :379-392

[35] Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells [J].

Leong, Jeffrey W. ;

Chase, Julie M. ;

Romee, Rizwan ;

Schneider, Stephanie E. ;

Sullivan, Ryan P. ;

Cooper, Megan A. ;

Fehniger, Todd A. .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (04) :463-473

[36] Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV [J].

Liu, Dongfang ;

Tian, Shuo ;

Zhang, Kai ;

Xiong, Wei ;

Lubaki, Ndongala Michel ;

Chen, Zhiying ;

Han, Weidong .

PROTEIN & CELL, 2017, 8 (12) :861-877

[37] Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers [J].

Liu, Y. ;

Cheng, Y. ;

Xu, Y. ;

Wang, Z. ;

Du, X. ;

Li, C. ;

Peng, J. ;

Gao, L. ;

Liang, X. ;

Ma, C. .

ONCOGENE, 2017, 36 (44) :6143-6153

[38] Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis [J].

Lu, Xuzhang ;

Ohata, Kinya ;

Kondo, Yukio ;

Espinoza, J. Luis ;

Qi, Zhirong ;

Nakao, Shinji .

CANCER SCIENCE, 2010, 101 (03) :609-615

[39] T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia [J].

Mardiros, Armen ;

Dos Santos, Cedric ;

McDonald, Tinisha ;

Brown, Christine E. ;

Wang, Xiuli ;

Budde, L. Elizabeth ;

Hoffman, Lauren ;

Aguilar, Brenda ;

Chang, Wen-Chung ;

Bretzlaff, William ;

Chang, Brenda ;

Jonnalagadda, Mahesh ;

Starr, Renate ;

Ostberg, Julie R. ;

Jensen, Michael C. ;

Bhatia, Ravi ;

Forman, Stephen J. .

BLOOD, 2013, 122 (18) :3138-3148

[40] Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer [J].

Miller, JS ;

Soignier, Y ;

Panoskaltsis-Mortari, A ;

McNearney, SA ;

Yun, GH ;

Fautsch, SK ;

McKenna, D ;

Le, C ;

Defor, TE ;

Burns, LJ ;

Orchard, PJ ;

Blazar, BR ;

Wagner, JE ;

Slungaard, A ;

Weisdorf, DJ ;

Okazaki, IJ ;

McGlave, PB .

BLOOD, 2005, 105 (08) :3051-3057

← 1 2 3 4 5 6 7 8 →